Skip to main content
. Author manuscript; available in PMC: 2014 Apr 8.
Published in final edited form as: J Am Board Fam Med. 2013 Nov-Dec;26(6):692–700. doi: 10.3122/jabfm.2013.06.130003

Table 2.

Pain, disability and functional status

BPI Pain Severity (0–10) BPI Pain Interference (0–10) SF12 Physical Health (0–100) SF12 Mental Health (0–100) SF12-Fair/Poor General Health CPGS Disability Score (0–100%) CPGS - Characteristic Pain Intensity (0–100%) PFD-Days with pain last 2 weeks (0–14) PIQ-6 (40–78)
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI n % Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
6 weeks prior to baseline 6.9 (6.6, 7.1) 6.9 (6.6, 7.3) - - - - - - 72.6 (69.1, 76.1) 78.6 (76.8, 80.3) 13.0 (12.6, 13.3) 68.4 (67.5, 69.2)
4 weeks prior to baseline 6.9 (6.6, 7.2) 6.6 (6.2, 7) - - - - - - - - - - 12.5 (12, 12.9) - -
2 weeks prior to baseline 7.0 (6.6, 7.4) 6.5 (6, 7) - - - - - - - - - - 12.5 (11.9, 13) - -
Baseline 6.7 (6.5, 7) 6.4 (6, 6.8) 31.7 (30.4, 33.1) 38.2 (36.2, 40.1) 107 46.7 66.8 (62.8, 70.8) 77.3 (75.2, 79.3) 12.3 (11.9, 12.8) 67.4 (66.4, 68.3)
2 week follow-up 6.2 (5.8, 6.5) 5.5 (5, 5.9) - - - - - - - - - - 11.1 (10.5, 11.8) 63.9 (62.7, 65.2)
4 week follow-up 5.7 (5.3, 6.1) 5.0 (4.5, 5.6) - - - - - - - - - - 10.7 (10, 11.4) 62.3 (60.9, 63.7)
8 week follow-up 5.6 (5.2, 6) 5.0 (4.4, 5.6) - - - - - - - - - - 10.7 (9.9, 11.4) 61.5 (59.9, 63.1)
12 week follow-up 5.6 (5.2, 6.1) 4.9 (4.3, 5.5) 35.7 (33.8, 37.6) 43.7 (41, 46.4) 52 40.63 43.7 (37.7, 49.8) 65.1 (61.2, 69.1) 10.1 (9.3, 10.9) 61.8 (60.1, 63.4)
16 week follow-up 5.7 (5.2, 6.3) 5.0 (4.4, 5.7) - - - - - - - - - - 10.6 (9.7, 11.5) 61.7 (59.9, 63.5)
24 week follow-up 5.5 (4.9, 6.1) 5.0 (4.4, 5.7) 35.3 (33, 37.5) 45.2 (42.5, 47.8) 36 33.64 45.2 (38.2, 52.2) 64.7 (59.9, 69.5) 10.9 (10, 11.7) 62.2 (60.2, 64.1)

- Not measured;

*

higher BPI score = more severe pain; higher SF-12 score = better function